The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma. Clinical Cancer Research , 2023 ...

The study aims to uncover the immunological basis of Tanshi (phlegm-dampness) constitution—a subhealth type in traditional ...

Diakonos Oncology reports that an interim analysis of a Phase I open label trial of its dendritic cell vaccine (DOC1021) showed substantially increased survival of glioblastoma multiforme (GBM ...

Scientists have pinpointed a crucial network of immune cells that allows humans to digest food safely without triggering ...

Autoimmune diseases: Abnormal dendritic cell activation and presentation of self-antigens may contribute to autoimmune diseases like rheumatoid arthritis, lupus erythematosus, autoimmune myocarditis, ...

A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk ...

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a type of blood cancer that affects immune system cells. It most often affects the skin but can also involve bone marrow and other cell types.

Follicular dendritic cell sarcoma in the right chest wall Hongli X and others Medicine (Baltimore), 2020. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic ...

In a subgroup analysis of the 176-patient trial, however, progression-free survival was significantly better with the dendritic cell therapy in patients with non-epithelioid histology (5.7 vs 2.9 ...

Diakonos Oncology’s dendritic cell immunotherapy previously received Fast Track designation for glioblastoma multiforme. Results from a phase 1 trial (ClinicalTrials.gov Identifier: ...